- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT04867239
A Two-day Education Program for Metabolic Syndrome Patients
29. april 2021 opdateret af: Sang Yeoup Lee, Pusan National University Yangsan Hospital
Temporal Changes of Metabolic Indicators and Quality of Life by a Two-day Patient Education Program for Metabolic Syndrome Patients
This study was to evaluate the temporal change of metabolic indicators and quality of life by a two-day patient education program.
Studieoversigt
Status
Afsluttet
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
This study aimed to evaluate whether a two-day multidisciplinary education camp comprising doctors, nurses, exercise instructors, dietitians, social workers, and health administrators could initiate healthy lifestyle habits, improve health markers though lifestyle modification, increase knowledge and understanding of the disease, and have a profitable effect on mental health in relation to depression and quality of life for patients with metabolic syndrome.
Undersøgelsestype
Interventionel
Tilmelding (Faktiske)
29
Fase
- Ikke anvendelig
Deltagelseskriterier
Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.
Berettigelseskriterier
Aldre berettiget til at studere
45 år og ældre (Voksen, Ældre voksen)
Tager imod sunde frivillige
Ingen
Køn, der er berettiget til at studere
Alle
Beskrivelse
Inclusion Criteria:
- people satisfied with metabolic syndrome criteria
Exclusion Criteria:
- None
Studieplan
Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Støttende pleje
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Andet: A two-day education program
During the camp, the multidisciplinary team provided disease information, lifestyle modification, nutrition, and exercise for metabolic syndrome.
Participants visited at 3- and 6-month after camp for follow-up.
|
During the camp, the multidisciplinary team provided disease information, lifestyle modification, nutrition, and exercise.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Waist circumference (cm)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in waist circumference at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Blood pressure (mmHg)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in blood pressure at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Korean version of EuroQol-5D (the minimum-maximum value, 0-1)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in score of Korean version of EuroQol-5D at 3-month and 6-month after camp.
Higher scores mean a better outcome.
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Korean version of Beck depression inventory-II (the minimum-maximum value, 0-63)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in score of Korean version of Beck depression inventory-II at 3-month and 6-month after camp.
Higher scores mean a worse outcome.
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Korean version of Beck anxiety inventory (the minimum-maximum value, 0-63)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in score of Korean version of Beck anxiety inventory at 3-month and 6-month after camp.
Higher scores mean a worse outcome.
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Nutritional knowledge score (the minimum-maximum value, 0-20)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in nutritional knowledge score at 3-month and 6-month after camp.
Higher scores mean a better outcome.
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Total cholesterol (mg/dL)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in total cholesterol (mg/dL) level at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
|
Triglyceride (mg/dL)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in triglyceride (mg/dL) level at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
|
HDL cholesterol (mg/dL)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in HDL cholesterol (mg/dL) level at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
|
LDL cholesterol (mg/dL)
Tidsramme: Change from pre-camp at 3-month and 6-month after camp
|
Change in LDL cholesterol (mg/dL) level at 3-month and 6-month after camp
|
Change from pre-camp at 3-month and 6-month after camp
|
Samarbejdspartnere og efterforskere
Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.
Datoer for undersøgelser
Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.
Studer store datoer
Studiestart (Faktiske)
23. maj 2014
Primær færdiggørelse (Faktiske)
23. november 2014
Studieafslutning (Faktiske)
30. november 2014
Datoer for studieregistrering
Først indsendt
27. april 2021
Først indsendt, der opfyldte QC-kriterier
27. april 2021
Først opslået (Faktiske)
30. april 2021
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
4. maj 2021
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
29. april 2021
Sidst verificeret
1. april 2021
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 05-2014-039
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Ingen
Studerer et amerikansk FDA-reguleret enhedsprodukt
Ingen
produkt fremstillet i og eksporteret fra U.S.A.
Ingen
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Metabolisk syndrom
-
Consorcio Centro de Investigación Biomédica en...Hospital General Universitario Gregorio Marañon; Universidad Complutense... og andre samarbejdspartnereIkke rekrutterer endnuLeverfibrose/NASH | MASH - Metabolic Dysfunction-Associated Steatohepatitis | MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseSpanien
-
Rivus Pharmaceuticals, Inc.RekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisForenede Stater
-
Madrigal Pharmaceuticals, Inc.RekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisForenede Stater
-
Shanghai East HospitalRekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisKina
-
Southern California Institute for Research and...Ikke rekrutterer endnuMASH - Metabolic Dysfunction-Associated Steatohepatitis
-
Nabiqasim Industries (Pvt) LtdRekrutteringMASH - Metabolic Dysfunction-Associated SteatohepatitisPakistan
-
Fondazione Policlinico Universitario Agostino Gemelli...RekrutteringMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseItalien
-
Tangram Therapeutics PlcRekrutteringSunde deltagere | MASH - Metabolic Dysfunction-Associated SteatohepatitisDet Forenede Kongerige
-
University of Campania Luigi VanvitelliAfsluttetMASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseItalien
-
University Hospital, Basel, SwitzerlandIkke rekrutterer endnuKardiovaskulær-Kidney-metabolsk syndrom | Cradiovascular-Kidney-Liver-Metabolic (CKLM) syndromSchweiz
Kliniske forsøg med A two-day education progra
-
Erzurum Technical UniversityAfsluttetFastende stat | Kognitive evnerTyrkiet (Türkiye)
-
University of UtahUniversity of Colorado, DenverAfsluttetDiabetes mellitusForenede Stater
-
CooperVision, Inc.Afsluttet
-
Alcon ResearchAfsluttetNærsynethed | Hyperopi | Refraktiv AmetropiaForenede Stater
-
Alcon ResearchAfsluttetKeratokonjunktivitis | Hornhindeødem | Hornhinde sår | Bulløs keratopati | Bell Parese | Hornhindedystrofi | Entropion | Filamentær keratitis | Erosion af hornhinden | Fremmedlegeme i hornhinden | Sicca syndrom; Keratokonjunktivitis (ætiologi)Forenede Stater
-
Micropharma LimitedAfsluttetHyperkolesterolæmiCanada
-
Alcon ResearchAfsluttet
-
Alcon ResearchAfsluttetHornhindeødem | Bulløs keratopati | Hornhindedystrofi | Entropion | Erosion af hornhindenForenede Stater
-
Alcon ResearchAfsluttet
-
Alcon ResearchAfsluttet